TELADOC HEALTH, INC. Interest Expense
TELADOC HEALTH, INC. (TDOC) reported Interest Expense of $5.76 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-05-01
- TELADOC HEALTH, INC. interest expense for the quarter ending 2025-03-31 was $5.76M, a 2.05% increase year-over-year.
- TELADOC HEALTH, INC. interest expense for the quarter ending 2024-12-31 was $6.85M, a 23.62% increase year-over-year.
- TELADOC HEALTH, INC. interest expense for the quarter ending 2024-09-30 was $5.66M, a 0.25% increase year-over-year.
- TELADOC HEALTH, INC. interest expense for the quarter ending 2024-06-30 was $5.65M, a 3.20% decline year-over-year.
- TELADOC HEALTH, INC. interest expense for fiscal 2024 was $23.80M, a 6.83% increase from fiscal 2023.
- TELADOC HEALTH, INC. interest expense for fiscal 2023 was $22.28M, a 1.54% increase from fiscal 2022.
- TELADOC HEALTH, INC. interest expense for fiscal 2022 was $21.94M, a 72.96% decline from fiscal 2021.
- TELADOC HEALTH, INC. interest expense for fiscal 2021 was $81.14M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $5.76M 10-Q · filed 2025-05-01 | $12.61M derived: sum of 2 quarters · filed 2025-05-01 | $18.27M derived: sum of 3 quarters · filed 2025-05-01 | $23.92M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.51M derived: sum of 2 quarters · filed 2025-02-27 | $18.15M derived: sum of 3 quarters · filed 2025-02-27 | $23.80M 10-K · filed 2025-02-27 |
| 2024-09-30 | $5.66M 10-Q · filed 2024-10-31 | $11.31M derived: sum of 2 quarters · filed 2024-10-31 | $16.96M 10-Q · filed 2024-10-31 | $22.50M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-06-30 | $5.65M 10-Q · filed 2024-08-01 | $11.30M 10-Q · filed 2024-08-01 | $16.84M derived: sum of 3 quarters · filed 2025-05-01 | $22.48M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-03-31 | $5.65M 10-Q · filed 2025-05-01 | $11.19M derived: sum of 2 quarters · filed 2025-05-01 | $16.83M derived: sum of 3 quarters · filed 2025-05-01 | $22.67M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.18M derived: sum of 2 quarters · filed 2025-02-27 | $17.02M derived: sum of 3 quarters · filed 2025-02-27 | $22.28M 10-K · filed 2025-02-27 |
| 2023-09-30 | $5.65M 10-Q · filed 2024-10-31 | $11.48M derived: sum of 2 quarters · filed 2024-10-31 | $16.74M 10-Q · filed 2024-10-31 | $21.33M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.83M 10-Q · filed 2024-08-01 | $11.10M 10-Q · filed 2024-08-01 | $15.69M derived: sum of 3 quarters · filed 2025-02-27 | $21.84M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $5.26M 10-Q · filed 2024-04-26 | $9.85M derived: sum of 2 quarters · filed 2025-02-27 | $16.00M derived: sum of 3 quarters · filed 2025-02-27 | $21.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.74M derived: sum of 2 quarters · filed 2025-02-27 | $16.30M derived: sum of 3 quarters · filed 2025-02-27 | $21.94M 10-K · filed 2025-02-27 |
| 2022-09-30 | $6.15M 10-Q · filed 2023-10-27 | $11.71M derived: sum of 2 quarters · filed 2023-10-27 | $17.36M 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $5.56M 10-Q · filed 2023-07-28 | $11.21M 10-Q · filed 2023-07-28 | ||
| 2021-12-31 | $81.14M 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |